{"data":[{"accessionNo":"0002063423-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-09-21","reportingPerson":"Readout Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3453388,"percentOfClass":5.4,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0002063423-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-09-21","reportingPerson":"Readout Capital GP, LLC","reportingCik":null,"personType":"HC","sharesOwned":3453388,"percentOfClass":5.4,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0002063423-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-09-21","reportingPerson":"Matthew Smith","reportingCik":null,"personType":"HC,IN","sharesOwned":3453388,"percentOfClass":5.4,"filedAt":"2026-09-25","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000902664-26-003526","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Weston Nichols","reportingCik":null,"personType":"IN","sharesOwned":20519148,"percentOfClass":13.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000902664-26-003526","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Lynx1 Capital Management LP","reportingCik":null,"personType":"PN","sharesOwned":20519148,"percentOfClass":13.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":6417831,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":6417831,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":6417831,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":6311239,"percentOfClass":9.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3649002,"percentOfClass":5.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":3649002,"percentOfClass":5.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2662237,"percentOfClass":4.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":2662237,"percentOfClass":4.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":83135,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":83135,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":5578288,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":5578288,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":5578288,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":4882815,"percentOfClass":8.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":3014267,"percentOfClass":5.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3014267,"percentOfClass":5.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1868548,"percentOfClass":3.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":1868548,"percentOfClass":3.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":560400,"percentOfClass":1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"},{"accessionNo":"0000921895-26-001399","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001783328","issuerName":"TScan Therapeutics, Inc.","ticker":"TCRX","cusip":"89854M101","securityClass":"Voting Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":560400,"percentOfClass":1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx"}],"updatedAt":"2026-11-04T08:01:39.101Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tcrx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}